Object reference not set to an instance of an object. Online Stock Broker - Stock Broking, Best Share Bazaar Brokers In India
Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c

Budget News

  • US Stocks surge on vaccines, stimulus optimism
  • March 02,2021  08:56
  • The US stocks climbed up on Monday, 01 March 2021, with the S&P 500, the Dow index, and the broader Nasdaq all to settling higher, as encouraging updates on COVID-19 vaccines and fiscal stimulus bolstered bets over a swift economic recovery.

    At the close of trade, the Dow Jones Industrial Average index advanced 603.14 points, or 1.95%, to 31,535.51. The S&P500 index dropped 90.67 points, or 2.38%, to 3,901.82. The tech-heavy Nasdaq Composite Index added 396.48 points, or 3.01%, to 13,588.83.

    Major indices leapt at the open and remained in positive territory the entire day, as investors cheered the emergency use approval of Johnson & Johnson's single-dose Covid-19 vaccine by US regulators over the weekend, giving the nation a third shot to battle the world's worst outbreak.

    The market also has been supported by expectations economic aid package after President Joe Biden scored his first legislative win as the House of Representatives passed his $1.9 trillion coronavirus relief package early Saturday. The bill now moves to the Senate.

    Market advance also came as the yield on 10-year Treasury notes, the benchmark borrowing cost in U.S. debt markets, slipped to 1.444% from 1.459% Friday

    Better-than-expected economic data is also helping with the good mood on Monday. America's manufacturing sector fared better than predicted in February, according to data from the Institute for Supply Management. The industry's purchasing managers' index, measuring activity, came in at 60.8. Any number above 50 denotes an expansion for the sector.

    Johnson & Johnson rose 1.8% as it began shipping its single-dose vaccine after it became the third authorized COVID-19 vaccine in the United States over the weekend.

    Boeing surged 5.8% after United Airlines announced a contract with the aerospace giant to add 25 more 737 MAX jets in 2023, reflecting optimism about a recovery in the travel industry.

    ECONOMIC NEWS: US Construction Spending Spikes 1.7% In January- US construction spending spiked by 1.7% to an annual rate of $1.522 trillion in January after jumping by 1.1% to a revised rate of $1.497 trillion in December, a report released by the Commerce Department on Monday showed. The bigger than expected increase in construction spending came as spending private construction surged up by 1.7% to an annual rate of $1.160 trillion. Spending on residential construction soared by 2.5% to a rate of $713.0 billion, while spending on non-residential construction rose by 0.4% to a rate of $447.0 billion. The report also showed spending on public construction jumped by 1.7% to an annual rate of $361.5 billion, partly reflecting a 5.8% spike in spending on highway construction. Compared to the same month a year ago, total construction spending in January was up by 1%.

    US Manufacturing Index Accelerated In February- US manufacturing PMI rose to 60.8 in February from 58.7 in January, with a reading above 50 indicating growth in the manufacturing sector, according to a report released by the Institute for Supply Management on Monday. The bigger than expected increase by the headline index came as the new orders index jumped to 64.8 in February from 61.1 in January.

    Powered by Capital Market - Live News

Top News
Global News

Follow us:

  • fb icon
  • Twitter icon
  • Linkedin
  • you tube
  • Instagram

Disclaimer:

SMC Global Securities Ltd | CIN : L74899DL1994PLC063609 | Registered Office: 11/6B, Shanti Chamber, Pusa Road, Delhi-110005. | Tel +91-11-30111000 | Compliance Officer: Mr. Ashok Kumar Aggarwal | Tel 011-30111000 Extn. 170 | Email:-aka@smcindiaonline.com| Customer Care Email –smc.care@smcindiaonline.com| Complaint Email –igc@smcindiaonline.com| website: www.smctradeonline.com

SEBI Reg. No. INZ000199438, Member: NSE (07714), BSE (470), MSEI (1002), MCX (8200) & NCDEX (00021). DP SEBI Regn. No. CDSL/NSDL-IN-DP-130-2015, SMC Research Analyst Registration- INH100001849, Mutual Funds Distributor ARN No. 29345. •Insurance services are offered through SMC Insurance Brokers Pvt. Ltd. IRDAI Regn. No: DB 272/04 License No. 289 Valid upto 27/01/2026. • Real Estate Advisory services are offered through SMC Real Estate Advisors Pvt. Ltd.

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. PMS is not offered in commodity derivative segment. Insurance is the subject matter of solicitation. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise.

By submitting your details to SMC, you are authorizing us to send promotional communication through Call/Email/SMS/Whatsapp even though you may be registered under DND.

OUR OTHER WEBSITES Go
IMPORTANT LINKS Go
QUICK LINKS
Go

Toll-free : 1800-11-0909
Email: contact@smctradeonline.com

Sitemap
Plus Minus 
Copyright ©2016-2024 SMC. All Rights Reserved | Disclaimer | Privacy Policy | Copyright| Testimonials| Sitemap| Grievance| design agency: triverse| Powered by C-MOTS Infotech (ISO 9001:2015 certified)

Open my trading account now!  X 

* All fields are compulsory